Levobupivacaine Altan

Levobupivacaine, the active ingredient in Levobupivacaine Altan, is a local anesthetic (amide) presented as a sterile solution for injection for epidural, infiltration, intrathecal and peripheral nerve block use. It provides reversible blockade of nerve impulse transmission to achieve surgical and obstetric analgesia.

GNH USA supplies Levobupivacaine Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is a local anesthetic used for regional anesthesia and analgesia.

- Epidural analgesia: provides pain relief during labor or postoperative periods. - Infiltration anesthesia for surgical procedures: creates localized numbness for minor surgeries. - Intrathecal anesthesia: enables spinal anesthesia for cesarean sections or lower‑limb procedures. - Peripheral nerve block: produces targeted anesthesia for limb surgeries.

Levobupivacaine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Dizziness or light‑headedness. - Nausea or vomiting. - Metallic taste in the mouth. - Headache at the injection site.

Serious or Rare Side Effects: - Seizures: central nervous system toxicity. - Cardiac arrhythmia: irregular heart rhythm. - Respiratory depression: reduced breathing effort. - Prolonged motor block: extended loss of muscle function. - Allergic reaction: rash, itching, or anaphylaxis. - Systemic toxicity: signs of central or cardiovascular toxicity.

When using Levobupivacaine, clinicians should observe several safety measures.

- Cardiac monitoring: observe ECG in patients with known heart disease. - Hepatic function assessment: adjust use in severe liver impairment. - Incremental dosing: avoid large single bolus injections. - Aspiration before injection: prevent intravascular administration. - Pregnancy caution: limited data; weigh benefits against potential risks. - Store at room temperature: keep in original container, protect from light and moisture.

Levobupivacaine can interact with other drugs, affecting safety and efficacy.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine): increase cardiotoxicity. - Beta‑blockers (e.g., propranolol): may exacerbate bradycardia. - Other local anesthetics (e.g., bupivacaine): additive systemic toxicity.

Moderate Interactions (Monitor Closely): - Opioids (e.g., fentanyl): may potentiate sedation and respiratory depression. - NSAIDs (e.g., ketorolac): could increase bleeding tendency. - Diuretics (e.g., furosemide): may alter plasma concentration of the anesthetic.